Candida Auris Fungal Infections are Becoming Much More Common in the U.S.

The Centers for Disease Control and Prevention said Monday that the number of cases of that who were resistant to drugs rose in 2021. This makes it a more dangerous threat to public health. The fungus is resistant to several antifungal drugs, but the CDC says that healthy people don’t have to worry about it. Still, C. auris is an urgent threat, says the national public health agency, because it is resistant to medications.

People who are already sick, use invasive medical devices. They may spend a lot of time or a lot of time at a healthcare facility. The may get very sick or even die from it.

Estimation by CDC:

The CDC stated that the percentage is based on information from a limited number of patients. However, it estimates that between 30 and 60 percent of those who became ill due to the yeast ultimately passed away.

Dr. Meghan Lyman, an epidemiologist at the CDC, said, “The rapid rise in cases and their spread across the country is concerning”. She further said,” It shows how important it is to keep monitoring, expand lab capacity, speed up diagnostic tests, and stick to proven ways to prevent and control infections”.

Candida auris has been found in more than 30 countries. The first time we saw this in the U.S. The CDC said that between then and December 2021, there were 3,270 clinical cases in the U.S. In such cases, the patients were infected and 7,413 screening cases in which the fungus was present in patients but was not causing infection.

Rapid Increase in cases since 2019:

The study found that there were a lot more cases of C. auris between 2019 and 2021. It literally means that it was spreading more. More specifically, as of December 31, 2021, the U.S. had reported 3270 clinical cases and 7413 screening cases of C. auris. Each year, the increase in clinical cases went up by a bigger amount. In 2019, the increase was 44%, and in 2021, it was 95%.

The researchers also saw an increase in cases of resistance to echinocandins and signs of transmission. This is especially worrying because echinocandins are the first-line treatment for invasive Candida infections, like C. auris. To stop the spread of C. auris, these results show how important it is to improve ways to find infections and stop them from spreading.

Transferring virus is highly contagious:

It is possible to catch it from another person or through touching something that already has the virus on it.

The Centers for (CDC) speculate that insufficient attention to prevention, and lax control measures in healthcare settings. Moreover, better patient discovery may have contributed to the rise in reported cases.

The yeast can be identified by analyzing bodily fluids. However, the CDC shows concerns about it since it is difficult to distinguish from other types of yeast. Misdiagnosis over rules. It would make it more difficult to put a stop to the spread of the infection.

For More Latest Updates, Click Here.